National Comprehensive Cancer Network



About NCCN

NCCN Flash Update: NCCN Guidelines Updated

Flash Update Sent April 12, 2011

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) for Non-Melanoma Skin Cancers: Basal and Squamous Cell Skin Cancers; Dermatofibrosarcoma Protuberans; and Merkel Cell Carcinoma. These NCCN Guidelines™ are currently available as Version 1.2011.

Basal Cell and Squamous Cell Skin Cancer

  • Basal Cell Skin Cancer
  • The option of radiation therapy as primary treatment for low-risk and high-risk basal cell skin cancer changed from category 2B to category 2A.
  • Footnote k regarding clinical trials for metastatic basal cell carcinoma was revised to read, "Combination chemotherapy with cisplatin- or carboplatin-based doublets has produced useful responses."
  • Squamous Cell Skin Cancer
  • The option of radiation therapy as primary treatment for low-risk and high-risk squamous cell skin cancer changed from category 2B to category 2A.
  • The algorithm for preoperative assessment and treatment of palpable regional lymph node(s) or abnormal lymph nodes identified by imaging studies has been restructured. Concurrent chemotherapy in combination with radiation is recommended as an additional option for inoperable nodal-positive disease.

Merkel Cell Carcinoma

  • Staging tables for merkel cell carcinoma were added to reflect the 7th edition (2010) of the AJCC Staging Manual.

Flash Update Sent June 10, 2011

NCCN has published updates to the NCCN Guidelines for Non-Melanoma Skin Cancers: Basal and Squamous Cell Skin Cancers; Dermatofibrosarcoma Protuberans; and Merkel Cell Carcinoma. These NCCN Guidelines are currently available as Version 2.2011.

The Discussion sections of the NCCN Guidelines for Non-Melanoma Skin Cancers: Basal and Squamous Cell Skin Cancers; Dermatofibrosarcoma Protuberans; and Merkel Cell Carcinoma have been updated to correspond with the treatment algorithms.

For the complete updated version of these and all NCCN Guidelines, visit NCCN.org.